Evidence map›Paper›PMID 23647022›Full record

Observational studyThe British journal of dermatology2013

Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population.

J A Puig-Butillé, C Carrera, R Kumar, Z Garcia-Casado, C Badenas, P Aguilera, J Malvehy, E Nagore, S Puig

Open access · greenAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in The British journal of dermatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Age-specific melanoma risk associated with melanocytic nevi: a pooled analysis from the M-SKIP project.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Genetic analysis of melanocortin 1 receptor red hair color variants in a Russian population of Eastern Siberia.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2018
    Article
  10. Article
  11. Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma.Genetics in medicine : official journal of the American College of Medical Genetics · 2016
    Article
  12. Article
  13. Update in genetic susceptibility in melanoma.Annals of translational medicine · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

J A Puig-ButilléCentro Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain; Biochemical and Molecular Genetics Service, Department of Dermatology, Melanoma Unit, Hospital Clinic and IDIBAPS (Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer), Barcelona, Spain.
C Carrera
R Kumar
Z Garcia-Casado
C Badenas
P Aguilera
J Malvehy
E Nagore
S Puig
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESFundación Instituto Valenciano de Oncología · ESInstituto de Investigación de Enfermedades Raras · ESCentre for Biomedical Network Research on Rare Diseases · ESGerman Cancer Research Center · DEInstituto de Salud Carlos III · ES

Funding

Genetic Epidermiology of MelanomaR01CA083115 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BISHOP, DAVID TIMOTHY, ELDER, DAVID ERIC · 2001 to 2017
$13.0M
NCI NIH HHS CA83115NCI NIH HHS R01 CA083115
6 · The paper itself

Abstract

backgroundCutaneous melanoma tumour is classified into clinicohistopathological subtypes that may be associated with different genetic and host factors. Variation in the MC1R gene is one of the main factors of risk variation in sporadic melanoma. The relationship between MC1R variants and the risk of developing a specific subtype of melanoma has not been previously explored.

objectivesTo analyse whether certain MC1R variants are associated with particular melanoma subtypes with specific clinicohistopathological features.

methodsAn association study was performed between MC1R gene variants and clinicopathological subtypes of primary melanoma derived from 1679 patients.

resultsWe detected 53 MC1R variants (11 synonymous and 42 nonsynonymous). Recurrent nonsynonymous variants were p.V60L (30·0%), p.V92M (11·7%), p.D294H (9·4%), p.R151C (8·8%), p.R160W (6·2%), p.R163Q (4·2%) p.R142H (3·3%), p.I155T (3·8%), p.V122M (1·5%) and p.D84E (1·0%). Melanoma subtypes showed differences in the total number of MC1R variants (P = 0·028) and the number of red hair colour variants (P = 0·035). Furthermore, an association between p.R163Q and lentigo maligna melanoma was detected under a dominant model of heritance (odds ratio 2·16, 95% confidence interval 1·07-4·37; P = 0·044). No association was found between p.R163Q and Fitzpatrick skin phototype, eye colour or skin colour, indicating that the association was independent of the role of MC1R in pigmentation. No association was observed between MC1R polymorphisms and other melanoma subtypes.

conclusionsOur findings suggest that certain MC1R variants could increase melanoma risk due to their impact on pathways other than pigmentation, and may therefore be linked to specific melanoma subtypes.

Indexed as

Cutaneous Malignant MelanomaEye ColorGenetic VariationHair ColorHumansHutchinson's Melanotic FreckleMediterranean RegionMelanomaNucleotidesPhenotypePolymorphism, GeneticReceptor, Melanocortin, Type 1Retrospective StudiesRisk FactorsSkin NeoplasmsNucleotidesReceptor, Melanocortin, Type 1

Identifiers

PMID23647022
PMCPMC3863403
OpenAlexW1998203591

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.